Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Amphotericin B vs Normal Saline as Maintenance in CPA
NCT06447402Phase 3Recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b deoxycholate in chronic pulmonary aspergillosis (CPA), sponsored by Post Graduate Institute of Medical Education and Research. Started Jun 2024; status: recruiting.
02
Drugs
amphotericin b deoxycholate
03
Conditions
chronic pulmonary aspergillosis (CPA)
Beyond the preview
Go deeper on NCT06447402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06447402.